Saturday, February 25, 2017

Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients

Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients:

Dementia Big
Donepezil, a medication that is approved to treat people with Alzheimer’s disease, should not be prescribed for people with mild cognitive impairment without a genetic test.


http://ift.tt/2lG3p7E

No comments:

Post a Comment